These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 31106943)
1. Sertoli-Leydig cell tumor of the ovary: Analysis of a single institution database and review of the literature. Durmuş Y; Kılıç Ç; Çakır C; Yüksel D; Boran N; Karalök A; Boyraz G; Turan AT J Obstet Gynaecol Res; 2019 Jul; 45(7):1311-1318. PubMed ID: 31106943 [TBL] [Abstract][Full Text] [Related]
2. Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors. Gouy S; Arfi A; Maulard A; Pautier P; Bentivegna E; Leary A; Chargari C; Genestie C; Morice P Oncologist; 2019 May; 24(5):702-709. PubMed ID: 30201740 [TBL] [Abstract][Full Text] [Related]
3. Ovarian sertoli-leydig cell tumors: A multicenter long-term clinicopathological analysis of 27 patients. Akman L; Ertas IE; Gokcu M; Terek MC; Sanci M; Sanli UA; Zekioglu O; Ozsaran AA J Cancer Res Ther; 2016; 12(1):290-4. PubMed ID: 27072253 [TBL] [Abstract][Full Text] [Related]
4. A clinicopathological analysis of 40 cases of ovarian Sertoli-Leydig cell tumors. Gui T; Cao D; Shen K; Yang J; Zhang Y; Yu Q; Wan X; Xiang Y; Xiao Y; Guo L Gynecol Oncol; 2012 Nov; 127(2):384-9. PubMed ID: 22850410 [TBL] [Abstract][Full Text] [Related]
5. Sertoli-Leydig cell tumor of the ovary: analysis of a single institution database. Bhat RA; Lim YK; Chia YN; Yam KL J Obstet Gynaecol Res; 2013 Jan; 39(1):305-10. PubMed ID: 22691037 [TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic features of ovarian Sertoli-Leydig cell tumors. Zhang HY; Zhu JE; Huang W; Zhu J Int J Clin Exp Pathol; 2014; 7(10):6956-64. PubMed ID: 25400781 [TBL] [Abstract][Full Text] [Related]
7. Ovarian Sertoli-Leydig cell tumors. a retrospective MITO study. Sigismondi C; Gadducci A; Lorusso D; Candiani M; Breda E; Raspagliesi F; Cormio G; Marinaccio M; Mangili G Gynecol Oncol; 2012 Jun; 125(3):673-6. PubMed ID: 22446621 [TBL] [Abstract][Full Text] [Related]
8. Characteristics and outcomes analysis of ovarian Sertoli-Leydig cell tumors (SLCTs): analysis of 15 patients. Wang G; Zhang R; Li C; Chen A J Ovarian Res; 2021 Nov; 14(1):150. PubMed ID: 34736487 [TBL] [Abstract][Full Text] [Related]
9. Ovarian Sertoli-Leydig cell tumours: How typical is their typical presentation? Melero Cortés LM; Martínez Maestre MÁ; Vieites Pérez-Quintela MB; Gambadauro P J Obstet Gynaecol; 2017 Jul; 37(5):655-659. PubMed ID: 28485183 [TBL] [Abstract][Full Text] [Related]
10. Sertoli-Leydig cell tumor: a clinicopathological analysis in a comprehensive, national cohort. Bekker P; Miland-Samuelsen AR; Smerdel MP; Schnack TH; Lauszus FF; Karstensen SH Int J Gynecol Cancer; 2023 Dec; 33(12):1921-1927. PubMed ID: 37907261 [TBL] [Abstract][Full Text] [Related]
11. Ovarian Sertoli-Leydig cell tumors: an analysis of 13 cases. Guo Y; Wang J; Li Y; Wang Y Arch Gynecol Obstet; 2020 Jul; 302(1):203-208. PubMed ID: 32430758 [TBL] [Abstract][Full Text] [Related]
12. Ovarian Sertoli-Leydig cell tumors: a single institution experience and review of the literature. Gressel GM; Buza N; Pal L Eur J Gynaecol Oncol; 2017; 38(2):214-220. PubMed ID: 29953783 [TBL] [Abstract][Full Text] [Related]
13. Outcomes in ovarian Sertoli-Leydig cell tumor: A report from the International Pleuropulmonary Blastoma/DICER1 and Ovarian and Testicular Stromal Tumor Registries. Nelson AT; Harris AK; Watson D; Kamihara J; Chen KS; Stall JN; Devins KM; Young RH; Olson DR; Mallinger PHR; Mitchell SG; Hoffman LM; Halliday G; Suleymanova AM; Glade Bender JL; Messinger YH; Herzog CE; Field AL; Frazier AL; Stewart DR; Dehner LP; Hill DA; Billmire DF; Schneider DT; Schultz KAP Gynecol Oncol; 2024 Jul; 186():117-125. PubMed ID: 38657450 [TBL] [Abstract][Full Text] [Related]
14. DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors. Karnezis AN; Wang Y; Keul J; Tessier-Cloutier B; Magrill J; Kommoss S; Senz J; Yang W; Proctor L; Schmidt D; Clement PB; Gilks CB; Huntsman DG; Kommoss F Am J Surg Pathol; 2019 May; 43(5):628-638. PubMed ID: 30986800 [TBL] [Abstract][Full Text] [Related]
15. Recurrent Sertoli-Leydig cell tumor of ovary in 8-year-old girl. Turkyilmaz Z; Karabulut R; Ozbakir F; Pinarli G; Arda Inan M; Oguz A; Sonmez K Scott Med J; 2016 Feb; 61(1):56-9. PubMed ID: 27334531 [TBL] [Abstract][Full Text] [Related]
16. Sertoli-Leydig cell tumor in two siblings with DICER1 syndrome: A case report and literature review. Zhang Y; Ren M; Hong Y; Zhong Y; Cong X; Chen C; Liu Z; Man Y; Yang L Medicine (Baltimore); 2020 Jul; 99(27):e20806. PubMed ID: 32629665 [TBL] [Abstract][Full Text] [Related]
17. Sertoli-Leydig cell tumor of the ovary: a clinicopathologic study of 10 cases. Ayhan A; Tuncer ZS; Hakverdi AU; Yüce K; Ayhan A Eur J Gynaecol Oncol; 1996; 17(1):75-8. PubMed ID: 8750520 [TBL] [Abstract][Full Text] [Related]
18. Sertoli-Leydig cell tumor of ovary in children: A report of two cases, including retiform variant. Sarkar P; Sengupta M; Chatterjee U; Ghosh D Indian J Pathol Microbiol; 2021; 64(3):559-562. PubMed ID: 34341273 [TBL] [Abstract][Full Text] [Related]
19. Moderately differentiated Sertoli-Leydig cell tumor of ovary with associated mucinous carcinoma and carcinoid-A case report and review of literature. Ravichandaran A; Lakshmanan A; Kurian A; Prasad S Indian J Pathol Microbiol; 2021; 64(3):528-531. PubMed ID: 34341265 [TBL] [Abstract][Full Text] [Related]
20. Mucinous adenocarcinoma as heterologous element in intermediately differentiated Sertoli-Leydig cell tumor of the ovary. Virk R; Lu D Pathol Res Pract; 2010 Jul; 206(7):489-92. PubMed ID: 19674851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]